Cargando…
Is fibroblast growth factor 23 a new cardiovascular risk marker in gestational diabetes?
OBJECTIVE: This study was designed to compare the serum levels of fibroblast growth factor 23 (FGF23) among patients with gestational diabetes mellitus (GDM) and healthy pregnant women, and to evaluate the association between hormonal and metabolic parameters. SUBJECTS AND METHODS: A total of 82 pre...
Autores principales: | Kizilgul, Muhammed, Kan, Seyfullah, Beysel, Selvihan, Apaydin, Mahmut, Ozcelik, Ozgur, Caliskan, Mustafa, Ozbek, Mustafa, Ozdemir, Seyda, Cakal, Erman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Endocrinologia e Metabologia
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522065/ https://www.ncbi.nlm.nih.gov/pubmed/28977159 http://dx.doi.org/10.1590/2359-3997000000287 |
Ejemplares similares
-
Heart-type fatty acid binding protein levels in elderly diabetics without known cardiovascular disease
por: Beysel, Selvihan, et al.
Publicado: (2017) -
Parathyroidectomy improves cardiovascular risk factors in normocalcemic and hypercalcemic primary hyperparathyroidism
por: Beysel, Selvihan, et al.
Publicado: (2019) -
The effects of single high-dose or daily low-dosage oral colecalciferol treatment on vitamin D levels and muscle strength in postmenopausal women
por: Apaydin, Mahmut, et al.
Publicado: (2018) -
Clinical evaluation of pituitary insufficiency in adult population
por: BEYSEL, Selvihan, et al.
Publicado: (2020) -
Screening for celiac disease in poorly controlled type 2 diabetes mellitus: worth it or not?
por: Kizilgul, Muhammed, et al.
Publicado: (2017)